Business
MGC Pharma strikes exclusive world-wide product distribution agreement – Stockhead
Three-year deal with Swiss PharmaCan is for world-wide distribution of its anti-inflammatory product ‘We are very happy with the successful cooperation between…
Link copied toclipboard
- Three-year deal with Swiss PharmaCan is for world-wide distribution of its anti-inflammatory product
- ‘We are very happy with the successful cooperation between MGC and Swiss PharmaCan’ – Swiss PharmaCan CEO
- MGC Pharma to dispatch 40,000 units per quarter of its product to Swiss PharmaCan
Biopharma company MGC Pharmaceuticals (ASX:MXC) has stuck a worldwide supply and distribution agreement for its anti-inflammatory medicinal cannabis product that can be used to treat COVID-19.
…
Continue Reading
-
Noosa News23 hours agoQueensland government and nurses and midwives reach in-principle pay deal after months of negotiation
-
Noosa News12 hours agoPill checking to resume in Queensland months after government axed funding
-
Noosa News22 hours agoBrisbane nation’s third-youngest capital; Leaders condemn anti-immigration rally
-
Business15 hours agoWhy Austal, Boss Energy, Harvey Norman, and NextDC shares are charging higher today